Your browser doesn't support javascript.
loading
MLKL Requires the Inositol Phosphate Code to Execute Necroptosis.
Dovey, Cole M; Diep, Jonathan; Clarke, Bradley P; Hale, Andrew T; McNamara, Dan E; Guo, Hongyan; Brown, Nathaniel W; Cao, Jennifer Yinuo; Grace, Christy R; Gough, Peter J; Bertin, John; Dixon, Scott J; Fiedler, Dorothea; Mocarski, Edward S; Kaiser, William J; Moldoveanu, Tudor; York, John D; Carette, Jan E.
Afiliación
  • Dovey CM; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Diep J; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Clarke BP; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
  • Hale AT; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
  • McNamara DE; Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Guo H; Department of Microbiology, Immunology and Molecular Genetics, University of Texas Health Sciences Center, San Antonio, TX 78229, USA.
  • Brown NW; Department of Chemistry, Princeton University, Princeton, NJ 08544, USA; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.
  • Cao JY; Department of Biology, Stanford University, Stanford, CA 94305, USA.
  • Grace CR; Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Gough PJ; Host Defense Discovery Performance Unit, Infectious Diseases Therapy Area Unit, GlaxoSmithKline, Collegeville, PA 19426, USA.
  • Bertin J; Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, PA 19426, USA.
  • Dixon SJ; Department of Biology, Stanford University, Stanford, CA 94305, USA.
  • Fiedler D; Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.
  • Mocarski ES; Department of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Kaiser WJ; Department of Microbiology, Immunology and Molecular Genetics, University of Texas Health Sciences Center, San Antonio, TX 78229, USA.
  • Moldoveanu T; Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • York JD; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
  • Carette JE; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: carette@stanford.edu.
Mol Cell ; 70(5): 936-948.e7, 2018 06 07.
Article en En | MEDLINE | ID: mdl-29883610
ABSTRACT
Necroptosis is an important form of lytic cell death triggered by injury and infection, but whether mixed lineage kinase domain-like (MLKL) is sufficient to execute this pathway is unknown. In a genetic selection for human cell mutants defective for MLKL-dependent necroptosis, we identified mutations in IPMK and ITPK1, which encode inositol phosphate (IP) kinases that regulate the IP code of soluble molecules. We show that IP kinases are essential for necroptosis triggered by death receptor activation, herpesvirus infection, or a pro-necrotic MLKL mutant. In IP kinase mutant cells, MLKL failed to oligomerize and localize to membranes despite proper receptor-interacting protein kinase-3 (RIPK3)-dependent phosphorylation. We demonstrate that necroptosis requires IP-specific kinase activity and that a highly phosphorylated product, but not a lowly phosphorylated precursor, potently displaces the MLKL auto-inhibitory brace region. These observations reveal control of MLKL-mediated necroptosis by a metabolite and identify a key molecular mechanism underlying regulated cell death.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Quinasas / Neoplasias del Colon / Fosfatos de Inositol Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Quinasas / Neoplasias del Colon / Fosfatos de Inositol Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article